With high blood pressure affecting 1.3 billion people worldwide and standing as the leading risk factor for death, Nazata Bio has raised $430K in seed funding to tackle this critical health issue.
The digital therapeutics startup offers a personalized app designed to help patients lower their blood pressure by acting as a specialist dietitian, an exercise coach, and a behavioral scientist. Its core strength lies in a machine learning algorithm that tailors treatment for optimal individual results.
